Pear Therapeutics Obtains First Medicaid Coverage For PDTs
Massachusetts’ Medicaid program will cover reSET and reSET-O prescription digital therapeutics for the treatment of substance abuse disorder and opioid use disorder.
You may also be interested in...
Is Time Nearly Up For Pear? The PDT Company Could Be Bargain For Acquirer
Despite earlier efforts to restructure, the company is still struggling to meet its revenue targets, and issued a statement suggesting that further measures, including liquidation, may be necessary.
Minute Insight: Are Things Going Pear-Shaped For Digital Therapeutics?
Pear Therapeutics is restructuring itself to lower costs following repeated disappointing performances.
Pear Adds Spanish Version Of Its Addiction Therapy PDTs
Availability of Spanish-language prescription digital therapeutics for the treatment of substance use disorder and opioid use disorder will address important health equity and health care disparities, according to Pear.